About Igma Limited
Data last updated:
Igma Limited is a public limited company based in Raipur, Chhattisgarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24304CT2019PLC009496. Its GSTIN is 22AAFCI3883F1ZO (Chhattisgarh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹65 Lakh. It is led by directors including Aryan Khatri and Manohar Khatri.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 207 – 211 Aushadhi Vatika Medical Complex Dumartarai, Raipur, Chhattisgarh, India – 492015.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.68 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹6.8 Lakh (net margin -119.7%) and EBITDA of -₹5.72 Lakh (EBITDA margin -100.7%).
As per MCA filings, the company has open charges of ₹6.88 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
For more details, the company can be reached via its website igmalimited.com.
Company details
Contact details
Igma Limited's registered office is in Raipur, Chhattisgarh. Its website is igmalimited.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address207 – 211 Aushadhi Vatika Medical Complex Dumartarai, Raipur, Chhattisgarh, India – 492015
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Igma Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activities of Igma are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Igma Limited, buy the company report.
Financials of Igma Limited
FY 2023 filings availableIgma Limited reported revenue of ₹5.68 Lakh (down 98% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue fell 98% in the latest year. EBITDA fell 302% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹5.72 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹6.8 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -100.7% | ||
| Net Profit Margin | -119.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Igma Limited, buy the company report.
Board of directors of Igma Limited
Igma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aryan Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
| Manohar Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
| Avinash Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
Peer comparison
Igma Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alchemist Chemsynth Pharma Private Limited | ₹5.76 Lakh (FY 2025) | 19.0% | New Delhi, Delhi, India | |||
| Zebra Medicare India Private Limited | ₹5.74 Lakh (FY 2025) | 57.0% | Baddi, Himachal Pradesh, India | |||
| SPR Lifesciences Private Limited | ₹5.69 Lakh (FY 2021) | Hyderabad, Telangana, India | ||||
| Igma Limitedthis company | ₹5.68 Lakh (FY 2022) | -₹6.8 Lakh | -119.7% | -98.0% | Raipur, Chhattisgarh, India | |
| Invent Bio-Tech Private Limited | ₹5.66 Lakh (FY 2025) | -9.0% | Mau, Uttar Pradesh, India | |||
| Advision Industries Private Limited | ₹5.62 Lakh (FY 2022) | 370.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Igma Limited, buy the company report.
Auditor
Igma Limited is audited by RIJWANI & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RIJWANI & CO | FY 2020 | 025132C |
Shareholding
The shareholding of Igma Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Igma Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Oct 2025 | 101206761 | Hdfc Bank Limited | ₹6 Lakh | Open | |
| 20 Aug 2025 | 101140267 | Others | ₹6.45 Cr | Open | |
| 31 Mar 2025 | 101113642 | Hdfc Bank Limited | ₹36.71 Lakh | Open |
Total charge records: 3 View all charges
Legal cases
Igma Limited has 2 court cases on record: 2 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed against the company by Wings Pharmaceuticals P Ltd | Pending |
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Smartway Wellness Private Limited | Pending |
To see the full case history of Igma Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Igma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Igma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAFCI3883F1ZO | Chhattisgarh | Active | 28 Nov 2019 |
To see the full GST registrations and return filing status of Igma Limited, buy the company report.
Recent activity
Igma Limited has 3 board changes on record since 2019: 3 appointments. The latest: Aryan Khatri was appointed as Director on 28 Aug 2019.
Frequently asked questions
Igma is an active public limited company based in Raipur, Chhattisgarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2019 (7+ years old) and is registered under CIN U24304CT2019PLC009496.
Igma has 3 current directors:
- Aryan Khatri - Director
- Manohar Khatri - Director
- Avinash Khatri - Director
The latest financial statements of Igma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Igma is 22AAFCI3883F1ZO, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Igma is U24304CT2019PLC009496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Igma has 2 court cases on record: 2 filed against it. 2 are pending.
Igma was incorporated on 28 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Igma by revenue are Alchemist Chemsynth Pharma Private Limited, Zebra Medicare India Private Limited, SPR Lifesciences Private Limited, Invent Bio-Tech Private Limited, Advision Industries Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Aryan Khatri was appointed as Director on 28 Aug 2019. Avinash Khatri was appointed as Director on 28 Aug 2019. Manohar Khatri was appointed as Director on 28 Aug 2019.
Igma can be reached through the website igmalimited.com. Its registered office is in Raipur, Chhattisgarh, India.
The registered office of Igma is at 207 – 211 Aushadhi Vatika Medical Complex Dumartarai, Raipur, Chhattisgarh, India – 492015.